Preclinical research is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-04-23. Numbers and descriptions here follow the published literature rather than marketing material.
Dihexa is a synthetic peptide studied in laboratory research. It is often described as an angiotensin IV analog or a hepatocyte growth factor mimetic. The compound emerged from investigations into angiotensin IV and its effects on neural pathways. It is not an approved medication, and controlled human trials are lacking. In literature and online forums, it is discussed mainly as a research chemical. Its chemical name appears as N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) in some sources.
Development of dihexa has been linked to academic research on synaptogenesis, the formation of new synapses. Preclinical studies in rodents have examined its effects on learning and memory tasks. These studies are often cited in discussions about cognitive enhancement, but they do not establish safety or efficacy in humans. The compound's patent and commercial history is limited, and it is not widely available through pharmaceutical channels. Most information comes from animal models and in vitro experiments. Researchers continue to explore its basic biology rather than clinical applications.
Dihexa is not approved for human use in the United States or the European Union. It is commonly sold as a research chemical, a category that may not require the same regulatory review as medicines. Buyers should note that product labels may lack independent verification of identity or purity. The legal status can vary by country, and importation may be restricted. Reliable information about sourcing and quality is often scarce. Scientific publications typically use synthesized material from laboratories rather than commercial consumer products.
Storage recommendations for peptides and peptide-like compounds usually emphasize low temperatures, desiccation, and protection from light. A common practice is to keep dry powder at -20 °C or below and to prepare solutions shortly before use. Repeated freeze-thaw cycles may degrade the material, so aliquoting is often advised. Solubility depends on the solvent; aqueous solubility may be limited, and organic solvents such as dimethyl sulfoxide are sometimes used for stock solutions. Stability data specific to dihexa are sparse, so general peptide handling guidelines are often applied instead.
Analytical confirmation generally combines a separation method with a detection method. Reverse-phase high-performance liquid chromatography can assess purity, while mass spectrometry supports molecular identity. For research-grade material, a certificate of analysis may report a batch-specific purity value, but it does not guarantee biological activity or safety. Regulatory frameworks vary by country; many jurisdictions treat dihexa as a research chemical not intended for human consumption. Purchasers should verify local rules and supplier documentation. The absence of official standards makes independent testing and careful record-keeping important for laboratory work.
In laboratory settings, dihexa is typically handled as a research chemical rather than a pharmaceutical product. Suppliers may provide it as a lyophilized powder or in solution, and purity is often stated as a percentage determined by chromatographic analysis. Because independent verification is uncommon, researchers generally rely on certificates of analysis, which may include high-performance liquid chromatography and mass spectrometry data. The absence of pharmacopeial monographs means that identity, purity, and impurity profiles can vary between batches and suppliers.
| Property | Value | Notes |
|---|---|---|
| CAS Registry Number | 1401708-83-5 | Identifier used in chemical databases. |
| Common synonyms | P21; N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) | Names vary by supplier and publication. |
| Physical form | White to off-white powder | Lyophilized solid typical of peptides. |
| Solubility | Soluble in DMSO; limited in water | Aqueous preparation may need a co-solvent. |
| Storage | -20 °C, desiccated, protected from light | Reduce freeze-thaw cycles to maintain stability. |
Dihexa is a synthetic peptide with the chemical name N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, and it is structurally related to angiotensin IV, a naturally occurring peptide fragment. Researchers developed it as a modified analog intended to alter stability and activity relative to the parent peptide. Its short sequence and fatty acid chain distinguish it from many endogenous peptides, and published studies often describe it under the abbreviation dihexa. The compound is classified as a laboratory compound rather than an approved therapeutic in most jurisdictions.
Early laboratory work focused on its effects on synaptic connectivity and neuronal signaling. In cell and animal models, dihexa has been reported to promote the formation of new synapses, a process called synaptogenesis. These findings have generated interest in cognitive research, but the evidence base remains mostly preclinical. Human clinical trials with clear safety and efficacy endpoints are limited or absent in the public literature. Whether these effects translate to humans is an open question.
The proposed mechanism involves interaction with the hepatocyte growth factor (HGF) system and its receptor, c-Met. Dihexa is described in some studies as an HGF mimetic, meaning it may mimic or enhance HGF-mediated signaling. Activation of c-Met can influence cell growth, survival, and cytoskeletal remodeling, pathways that intersect with synaptic plasticity. However, the precise binding targets and downstream events for dihexa are not fully established, and alternative mechanisms have been suggested.
Research interest in dihexa centers on its ability to promote synapse formation in cultured neurons and in some rodent experiments. These findings have been interpreted as a possible mechanism for learning and memory effects, but the evidence remains preliminary. Independent replication is limited, and study designs vary widely in species, duration, and outcome measures. Human data are scarce, so claims about cognitive enhancement in people are not supported by robust clinical evidence. The gap between laboratory signals and proven clinical benefit is substantial.
Dihexa appears in scientific literature, patent documents, and commercial catalogs under several names, which can complicate searching and verification. The compound is frequently grouped with nootropics or research chemicals, terms that describe context of use rather than regulatory approval. Such labeling may imply benefits that have not been confirmed in controlled human studies. Readers encountering promotional descriptions should distinguish between preclinical observations and established medical facts. The absence of regulatory approval is a central feature of its current status.
Dihexa is a synthetic peptide-like compound studied in preclinical research for its reported effects on synaptic growth and cognitive measures in animal models. It is often described as an analog of angiotensin IV, a naturally occurring peptide fragment. The compound has not been approved as a medicine in any major jurisdiction. Most public information comes from laboratory studies, patents, and online vendor listings rather than from large clinical trials. Its scientific status therefore differs from that of an established pharmaceutical.
Every polyhedron has a dihedral angle at every edge describing the relationship of the two faces that share that edge. This dihedral angle, also called the face angle, is measured as the internal angle with respect to the polyhedron. An angle of 0° means the face normal vectors are antiparallel and the faces overlap each other, which implies that it is part of a degenerate polyhedron. An angle of 180° means the faces are parallel, as in a tiling. An angle greater than 180° exists on concave portions of a polyhedron. Every dihedral angle in a polyhedron that is isotoxal and/or isohedral has the same value. This includes the 5 Platonic solids, the 13 Catalan solids, the 4 Kepler–Poinsot polyhedra, the 2 convex quasiregular polyhedra, and the 2 infinite families of bipyramids and trapezohedra.
==== Spanish colonial America ==== In Jamaica and elsewhere in the Caribbean area, the Spanish enslaved many of the Taino natives. Some of them escaped, and some hurled themselves and their children off of cliffs to avoid enslavement, but most died from European diseases and overwork. The practice began under Christopher Columbus, who was looking for gold to finance his future expeditions, and was continued by the other conquistadors who followed in his wake. In 1519, Hernán Cortés brought the first modern slave to Mexico. In the mid-16th century, the Spanish New Laws, prohibited slavery of the indigenous people, including the Aztecs. A labour shortage resulted. This led to the African slaves being imported, as they were not susceptible to smallpox. In exchange, many Africans were afforded the opportunity to buy their freedom, while eventually others were granted their freedom by their masters. Spain practically did not trade in slaves until 1810 after the rebellions and independence of its American territories or viceroyalties. After the Napoleonic invasions, Spain had lost its industry and its American territories, except in Cuba and Puerto Rico, where the African slave trade to Cuba began on a massive scale from 1810 onwards. It was started by French planters exiled from the French lost colony Saint Domingue (Haiti) who settled in the eastern part of Cuba. In 1789, the Spanish Crown led an effort to reform slavery, as the demand for slave labour in Cuba was growing.
== Costs == Bone graft procedures consist of more than just the surgery itself. The complete three-month total cost of a complex posterolateral lumbar spine fusion bone graft supplemented with graft extenders ranges from a mean of approximately US$33,860 to US$37,227. This price includes all visits in and out of the hospital for three months. Besides the cost of the bone graft itself (ranging from US$250 to US$900) other expenses for the procedure include: outpatient rehabilitation fees (US$5,000 to US$7,000), screws and rods (US$7,500), room and board (US$5,000), operating room (US$3,500), sterile supplies (US$1,100), physical therapy (US$1,000), surgeon's fees (average US$3,500), anesthesiologist fees (approximately US$350 to US$400 per hour), medication charges (US$1,000), and additional fees for services such as medical supplies, diagnostic procedures, equipment use fees, etc.
is the distance traveled by the liquid. More extensive models account for paper tortuosity, pore radius, and paper deformation. Once the medium is fully wetted, subsequent flow is laminar and follows Darcy's law. The average velocity of fluid flow is generalized as,
Sources: en.wikipedia.org
== Writing career == Gaines began publishing short stories in the early 1990s. Her short story The Mouse was selected for The Best of the West 5, one in a series of annual anthologies of short stories, published annually from 1988 to 1992. Her novel Carbon Dreams was published in 2001. Set in the early 1980s, it tells the story of a woman who discovers a way to study climate in the distant past that may have relevance for the climate of the future, and about the scientific, ethical and personal controversies that she inadvertently becomes embroiled in. Elizabeth Wilson, writing in Chemical and Engineering News, called it a "step forward in the evolution of science-in-fiction.... A remarkable job of conveying what it's really like to be a scientist, and to make scientific discoveries - not in the blink of an eye, as television or movies would have it, but with gradually shifting insight." It is considered an early contribution to the Lab lit genre. Gaines's 2020 novel Accidentals is the story of an Uruguayan-American family, noted for its "melding of sensual landscapes with ruminations on political history and environmental devastation" and "critique of globalization." Like Carbon Dreams, it has been recognized as a "rare" and "well-written" example of a realist novel about science and compared to the work of Barbara Kingsolver.
Sarah Jane Cressall. Founder and Chief Executive Officer, The Creation Station. For services to Creativity in Education, Entertainment and Business. Thomas Daniel Critchley. Data Scientist, Prime Minister's Office. For services to Evidence-Based Policy. Dr. Ruth Louise Cromie. Research Fellow, Wildfowl and Wetlands Trust. For services to Wetland and Waterbird Conservation. Professor Adrian Michael Cruise. Emeritus Professor, University of Birmingham. For services to Space Science. Dr. Robert Nicholas Cullinan. Director, National Portrait Gallery. For services to Art. Laurence Alexander Cummings. Conductor, Harpsichordist, Music Director of the Academy of Ancient Music and the London Handel Festival, and William Crotch Professor of Historical Performance, Royal Academy of Music. For services to Music. Lynn Cummings, JP. Commercial Category Lead, Department for Work and Pensions. For Public Service. Professor William Cushley. Chair, Expert Committee on Pesticides. For services to the Regulation of Plant Protection Products. Dr. Dipankar Dutta. Chair, South Asia Voluntary Enterprise. For services to Charity. Roy Henry Dennis, MBE. Wildlife Conservationist. For services to Wildlife. Paul Anthony Denton. For services to Charity. Dr. Darrell Carmel De Souza. Lately Principal and Chief Executive Officer, Harrow College and Uxbridge College. For services to Further Education. Morag Deyes, MBE. Artistic Director, Dance Base, Edinburgh. For services to Dance. Angela Jane Charlotte Dickson, MBE. Co-Founder, The Brain Tumour Charity. For services to People with Brain Tumours.
Under CLIA, anyone, including patients and their families, laboratory personnel, and the general public, can submit anonymous complaints if there are concerns about the quality of laboratory testing. The most common CLIA complaints are concerns about a laboratory's operations, such as: unlabeled specimens, unqualified staff, record falsification, missing or incorrect test results and the confidentiality of patient information. For laboratories accredited by a laboratory Accreditation Organization (AO), complaints may be referred to the laboratory's AO. Though anyone may lodge a complaint, relatively few laboratory complaints have been filed. This may be due to a lack of publicity about complaint filing, since CLIA does not require that laboratory employees or patients be made aware of how to file a complaint, and to privacy concerns stemming from the lack of whistleblower protections. Other limiting factors include an increasing reliance on on-the-job (OTJ)- trained lab personnel who are unaware of regulatory requirements, foreign-sponsored H1b medical technologists fearing retaliatory deportation, and an aging workforce awaiting retirement. Laboratory whistleblowers may face countermeasures such as cover-ups, loss of income, position, or employment, punitive lawsuits, and attacks on their reputation, which would degrade their living conditions and dissuade them from bringing fraud to light. A June 2006 GAO report found that lab workers may file complaints infrequently due to concerns about retaliation and a lack of understanding of how to do so.
Sources: en.wikipedia.org
Sargramostim, sold under the brand name Leukine among others, is a recombinant granulocyte macrophage colony-stimulating factor (GM-CSF) that functions as an immunostimulator. It is administered via intravenous infusion or via subcutaneous injection.
The party manifesto resists expanding gender definitions and opposes their integration into school curriculums and government documents and official medical records, positioning its stance as a defence of traditional values and cultural norms. Some of the leader's comments on the "woke agenda" have been perceived by some as transphobic, misogynistic, and as employing dog-whistle rhetoric, whilst Latinopoulou has previously made remarks associating homosexuality with paedophilia amongst some gay rights activists as being a secret Trojan horse method for masking secret pedophilia legalization desires within the gay rights movement for some woke agenda advocates. On the Gaza war, the party supports Israel and condemned the October 7th attack as an attack on Western civilisation, though Latinopoulou later emphasized that both sides should respect the rules of war, particularly considering the safety of women and children. The party also condemned the April 2024 Iranian strikes on Israel. The party condemned the court ban on the Spartans political party in contesting in the 2024 European Parliament election in Greece as a violation of free elections and democratic rights and the setting of a dangerous legal precedent. The party supports the death penalty for heinous crimes such as murder, child rape and sex trafficking where and when evidence is overwhelming, which party leader Latinopoulou has repeatedly voiced support for in public interviews.
=== Adaptation strategies === Potato production is expected to decline in many areas due to hotter temperatures and decreased water availability. Conversely, production is predicted to become possible in high altitude and latitude areas where it has been limited by frost damage, such as in Canada and Russia. This will shift potato production to cooler areas, mitigating much of the projected decline in yield. However, this may trigger competition for land between potato crops and other land uses, mostly due to changes in water and temperature regimes. The other approach is through the development of varieties or cultivars which would be more adapted to altered conditions. This can be done through 'traditional' plant breeding techniques and genetic modification. These techniques allow for the selection of specific traits as a new cultivar is developed. Certain traits, such as heat stress tolerance, drought tolerance, fast growth/early maturation and disease resistance, may play an important role in creating new cultivars able to maintain yields under stressors induced by climate change. For instance, developing cultivars with greater heat stress tolerance would be critical for maintaining yields in countries with potato production areas near current cultivars' maximum temperature limits (e.g. Sub-Saharan Africa, India). Superior drought resistance can be achieved through improved water use efficiency (amount of food produced per amount of water used) or the ability to recover from short drought periods and still produce acceptable yields.
=== Purine metabolism === GMP synthase is the second step in the generation of GMP from IMP; the first step occurs when IMP dehydrogenase generates XMP, and then GMP synthetase is able to react with glutamine and ATP to generate GMP. IMP may also be generated into AMP by adenylosuccinate synthetase and then adenylosuccinate lyase.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide investigated in preclinical research. It is often classified as an angiotensin IV analog or an HGF mimetic. It is not an approved medicine.
No. Regulatory agencies have not approved dihexa for human use. It is sold as a research chemical in some markets, and human safety and efficacy data are lacking.
Laboratory studies have examined its effects on synapse formation and cognitive tasks in animals. These are early-stage findings. They do not prove benefits or safety in people.
Dry powder is usually kept frozen, desiccated, and protected from light. Solutions are often aliquoted to avoid repeated freeze-thaw cycles. Specific stability data for dihexa are limited, so general peptide storage practices are commonly used.